BioSpace News Archive

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces that Dr. Akil Jackson, Medical Director at BerGenBio, will be participating at the Sachs Associates Digital Novel Coronavirus Investment Forum on 8-9 July 2020.

International medical imaging IT and cybersecurity company Sectra will install its enterprise imaging solution in many of CHRISTUS Health’s U.S. locations.

Quantum Leap Healthcare Collaborative™ announced the initiation of an investigational treatment arm with Byondis’ [vic-]trastuzumab duocarmazine in the ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA)

Avantor, Inc., a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced the commencement of a private offering of dollar-denominated and euro-denominated senior notes to be issued by its wholly-owned subsidiary, Avantor Funding, Inc.

Avantor, Inc., a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenue estimates for the quarter ended June 30, 2020, in conjunction with a separately announced proposed offering of debt securities.

Cancer Research UK, the world’s largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and tools, are pleased to announce a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

A considerable rise in the cases of upper respiratory tract infections due to factors like dense pollution levels and frequent climate changes may bring good growth opportunities for the upper respiratory tract infection treatment market during the forecast period of 2019-2029.

Beta lactum antibiotics are type of antibiotic agents with beta lactum rings in their molecular structures.

The healthcare industry is moving with a massive pace towards transformation.